Featured Result on BioPortfolio for "emphysema"

Emphysema device maker obtains $35 million in funding round

A regulatory filing disclosed that Uptake Medical has secured $35 million in a funding round targeted at $41 million.  -More- 

Emphysema Search

 Channels 4 Associated Channels

• Advair Diskus

  Advair Diskus, a respiratory medicine produced by GSK, netted $3.6m in sales in 2009, making it the fourth most successfull drug (in terms of annual sales).   Advair is used in the treatment...

• Tricuspid Regurgitation

  Tricuspid regurgitation (tricuspid incompetence, tricuspid insufficiency) is leakage of blood backward through the tricuspid valve each time the right ventricle contracts.Tricuspid regurgitation is...

• Neutrophil elastase NE

  Neutrophil elastase (NE) is a serine protease, expressed mainly by neutrophils, that is capable of degrading a variety of structural proteins of the extracellular matrix. Infiltration of activated n...

• COPD

  COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus...

Search Whole site using Google